Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
17,649
Total Claims
$738K
Drug Cost
326
Beneficiaries
$2,265
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+93%
Cost per patient vs peers
$2,265 vs $1,174 avg
+12%
Brand preference vs peers
9.9% vs 8.9% avg
Brand vs Generic
Brand: 1,742 claims · $423K
Generic: 15,847 claims · $310K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Tetrabenazine | 51 | $122K |
| Apixaban | 533 | $89K |
| Dulaglutide | 44 | $29K |
| Patiromer Calcium Sorbitex | 64 | $29K |
| Empagliflozin | 119 | $20K |
| Sacubitril/Valsartan | 120 | $20K |
| Sitagliptin Phosphate | 80 | $14K |
| Atorvastatin Calcium | 1,689 | $13K |
| Tiotropium Bromide | 25 | $12K |
| Aripiprazole | 173 | $11K |
| Potassium Chloride | 611 | $11K |
| Fluticasone/Umeclidin/Vilanter | 14 | $8,358 |
| Insulin Aspart | 47 | $8,296 |
| Linagliptin | 59 | $7,608 |
| Ivabradine Hcl | 49 | $6,964 |
Prescribing Profile
Patient Profile
73
Avg Age
49%
Female
3.81
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data